Kimberly A Couch

Statistics

Publications

Citations

189

H-Index

Active since

2009

Affiliations

Novartis (Switzerland)(Current)

Kimberly A Couch is an author at Novartis (Switzerland) specializing in antimicrobial pharmacotherapy, pharmacology, and methicillin-resistant staphylococcus aureus treatment.

ORCID

Publications per year

2009–2023

Publications

In Vitro 24-Hour Time-Kill Studies of Vancomycin and Linezolid in Combination versus Methicillin-Resistant <i>Staphylococcus aureus</i>

Shveta Rani Singh, Alfred E. Bacon, David C. Young et al. · Antimicrobial Agents and Chemotherapy · 2009 · 52 citations · Full text

Pharmacy, Microbiology, Pharmacology +13

Real-world daptomycin use across wide geographical regions: results from a pooled analysis of CORE and EU-CORE

R.A. Seaton, Armando González-Ruiz, Kerry O. Cleveland et al. · Annals of Clinical Microbiology and Antimicrobials · 2016 · 52 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Implementing a Breastfeeding Toolkit for Nursing Education

Catherine Folker-Maglaya, Maureen E. Pylman, Kimberly A Couch et al. · The Journal of Perinatal & Neonatal Nursing · 2018 · 38 citations

Public Health, Health Education, Maternal Health Nursing +17

One-year postpartum anthropometric outcomes in mothers and children in the LIFE-Moms lifestyle intervention clinical trials

Suzanne Phelan, Rebecca G. Clifton, Debra Haire‐Joshu et al. · International Journal of Obesity · 2019 · 35 citations · Full text

Agriculture, Maternal Health, Obstetrics +15

A Real-world Multicenter Outpatient Experience of Ceftolozane/Tazobactam

Lucinda J. Van Anglen, Claudia P. Schroeder, Kimberly A Couch · Open Forum Infectious Diseases · 2023 · 12 citations · Full text

Pharmacy, Infectious Diseases, Microbiology +16

1–5 of 5